| A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants (NCT07460284) | Guangdong Raynovent Biotech Co., Ltd | 2026-03-15 |
| Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A (NCT07229807) | Guangdong Raynovent Biotech Co., Ltd | 2025-11-22 |
| A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes (NCT07139548) | Guangdong Raynovent Biotech Co., Ltd | 2025-08-31 |
| A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (NCT07139535) | Guangdong Raynovent Biotech Co., Ltd | 2025-08-31 |
| Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight (NCT06893016) | Guangdong Raynovent Biotech Co., Ltd | 2025-06-15 |
| Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin (NCT07362030) | Guangdong Raynovent Biotech Co., Ltd | 2025-04-14 |
| Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A (NCT06656026) | Guangdong Raynovent Biotech Co., Ltd | 2024-11-30 |
| A Study of RAY1225 in Participants With Impaired Kidney Function (NCT06613763) | Guangdong Raynovent Biotech Co., Ltd | 2024-09-11 |
| A Study of RAY1225 in Participants With Impaired Liver Function (NCT06577415) | Guangdong Raynovent Biotech Co., Ltd | 2024-08-26 |
| A Study of RAY1225 at Different Injection Sites in Participants With Different Body Sizes (NCT06577428) | Guangdong Raynovent Biotech Co., Ltd | 2024-07-30 |
| A Study of RAY1225 in Participants With Type 2 Diabetes (NCT06254274) | Guangdong Raynovent Biotech Co., Ltd | 2024-02-26 |
| Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease (NCT06248567) | Guangdong Raynovent Biotech Co., Ltd | 2024-01-15 |
| Pharmacokinetics of ZSP1273 in Elder Participants (NCT06157450) | Guangdong Raynovent Biotech Co., Ltd | 2023-10-11 |
| Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease (NCT06160622) | Guangdong Raynovent Biotech Co., Ltd | 2023-09-26 |
| Mass Balance Study of [14C]RAY1216 in Healthy Adult Male Subjects in China (NCT06362460) | Guangdong Raynovent Biotech Co., Ltd | 2023-09-18 |
| Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Hepatic Impairment (NCT06161259) | Guangdong Raynovent Biotech Co., Ltd | 2023-09-14 |
| Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin (NCT06031454) | Guangdong Raynovent Biotech Co., Ltd | 2023-09-01 |
| Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid (NCT05954624) | Guangdong Raynovent Biotech Co., Ltd | 2023-07-10 |
| A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam (NCT05942365) | Guangdong Raynovent Biotech Co., Ltd | 2023-06-25 |
| Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment (NCT05856513) | Guangdong Raynovent Biotech Co., Ltd | 2023-06-15 |
| A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH) (NCT05692492) | Guangdong Raynovent Biotech Co., Ltd | 2023-06-03 |
| The Safety, Tolerability and Pharmacokinetic Study of RAY1225 (NCT05835752) | Guangdong Raynovent Biotech Co., Ltd | 2023-05-18 |
| Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in China (NCT05873426) | Guangdong Raynovent Biotech Co., Ltd | 2023-03-25 |
| Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19 (NCT05620160) | Guangdong Raynovent Biotech Co., Ltd | 2022-11-12 |
| The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants (NCT05829551) | Guangdong Raynovent Biotech Co., Ltd | 2022-05-20 |
| Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF） (NCT05119972) | Guangdong Raynovent Biotech Co., Ltd | 2021-10-21 |
| A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A (NCT04683406) | Guangdong Raynovent Biotech Co., Ltd | 2020-12-28 |
| Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir (NCT05108051) | Guangdong Raynovent Biotech Co., Ltd | 2020-11-19 |
| Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH) (NCT04140123) | Guangdong Raynovent Biotech Co., Ltd | 2020-06-23 |
| Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A (NCT04024137) | Guangdong Raynovent Biotech Co., Ltd | 2019-12-07 |